Home/Filings/4/0001127602-17-031636
4//SEC Filing

de Carbonnel Francois 4

Accession 0001127602-17-031636

CIK 0000318154other

Filed

Nov 7, 7:00 PM ET

Accepted

Nov 8, 5:39 PM ET

Size

5.1 KB

Accession

0001127602-17-031636

Insider Transaction Report

Form 4
Period: 2017-11-08
Transactions
  • Sale

    Common Stock

    2017-11-08$173.61/sh4,000$694,42215,528 total
Footnotes (2)
  • [F1]$173.6055 is an average price. The prices ranged from $173.57 to $173.64 per share. Full information regarding the number of shares sold at each separate price within the range set forth above is available upon request by the SEC staff, the issuer or a security holder of the issuer.
  • [F2]These shares include 277 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. 2009 Director Equity Incentive Program, as amended, and subject to a qualifying dividend reinvestment plan. DEs are credited on the director's vested but deferred Restricted Stock Units and are paid out in shares of the Company's Common Stock on a one-to-one basis along with a cash payment for any remaining fractional share amount.

Issuer

AMGEN INC

CIK 0000318154

Entity typeother

Related Parties

1
  • filerCIK 0001447121

Filing Metadata

Form type
4
Filed
Nov 7, 7:00 PM ET
Accepted
Nov 8, 5:39 PM ET
Size
5.1 KB